Lung cancer patients with a rare form of the disease are being offered a free medicine from Roche pharmaceuticals which helps stop its spread. Lung Foundation CEO Philip Hope talks to Jesse Mulligan about who might benefit from the drug and why there's an ongoing battle to have more effective drugs made available for patients with other forms of lung cancer.
New Zealand Lung Foundation CEO Philip Hope Photo: supplied
